COO, MCAL Therapeutics
Early-stage biotech dedicated to the discovery and development of innovative ophthalmic therapies.
Invited by: Mar Perez
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
March 18, 2024 | 243 | -4 | -1.7% |
April 10, 2023 | 247 | -3 | -1.2% |
October 03, 2022 | 250 | +1 | +0.5% |
August 11, 2022 | 249 | +1 | +0.5% |
July 06, 2022 | 248 | +4 | +1.7% |
May 29, 2022 | 244 | +2 | +0.9% |
March 14, 2022 | 242 | +2 | +0.9% |
January 16, 2022 | 240 | +6 | +2.6% |
December 09, 2021 | 234 | +13 | +5.9% |
October 31, 2021 | 221 | +4 | +1.9% |